Product Information
TASIMELTEON 20 MG CAPSULE is a generic product labeled by Apotex Corp., priced at $228.2480 per EA under NDC 60505466503. Its NADAC has been published 107 times since Sep 18, 2024.
FDA first approved this application on Dec 20, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Apotex Corp.NDC
60505466503
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TASIMELTEONApproval Type
Generic (ANDA)
FDA Application
ANDA211607FDA Approved
12/20/2022
TE Code
AB
On Market Since
1/5/2024
Pharmacological Classes
Price Statistics
The NADAC for TASIMELTEON 20 MG CAPSULE has been published 107 times since Sep 18, 2024, and over the history we have for it it has declined 62.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $228.2480 per EA |
|---|---|
| All-time high | $608.5590 (Sep 10, 2025) |
| All-time low | $228.2480 (Sep 23, 2026) |
| 52-week high | $419.0111 |
| 52-week low | $228.2480 |
| Median price | $419.0111 |
| Average price | $484.6787 |
| Largest weekly change | -31.1% (Sep 17, 2025) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tasimelteon market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Melatonin Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TASIMELTEON 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TASIMELTEON 20 MG CAPSULE, manufactured by Apotex Corp., is $228.2480 per EA (NDC 60505466503), effective Sep 30, 2026.
How has the price of TASIMELTEON 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TASIMELTEON 20 MG CAPSULE has declined 62.5%. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for TASIMELTEON 20 MG CAPSULE?
Since Sep 18, 2024, the NADAC for TASIMELTEON 20 MG CAPSULE has ranged from a low of $228.2480 (Sep 23, 2026) to a high of $608.5590 (Sep 10, 2025), with a median of $419.0111 per EA.
Are there cheaper alternatives to TASIMELTEON 20 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TASIMELTEON 20 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TASIMELTEON 20 MG CAPSULE?
TASIMELTEON 20 MG CAPSULE (NDC 60505466503) is labeled by Apotex Corp., and CMS classifies it as a generic product.